QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$46.55+0.42 (+0.91%)
Close on Oct 19, 2026Market cap –P/E 24.0Yield 0.54%
Qiagen net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was $424.88M, up 408.3% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is $512.60M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $424.88M | +408.3% |
| FY2024 | Dec 31, 2024 | $83.59M | -75.5% |
| FY2023 | Dec 31, 2023 | $341.30M | -19.4% |
| FY2022 | Dec 31, 2022 | $423.21M | -17.4% |
| FY2021 | Dec 31, 2021 | $512.60M | +42.7% |
| FY2020 | Dec 31, 2020 | $359.19M | – |
| FY2019 | Dec 31, 2019 | -$41.46M | -121.8% |
| FY2018 | Dec 31, 2018 | $190.38M | +371.3% |
| FY2017 | Dec 31, 2017 | $40.39M | -49.8% |
| FY2016 | Dec 31, 2016 | $80.40M | -38.2% |
| FY2015 | Dec 31, 2015 | $130.15M | +11.8% |
| FY2014 | Dec 31, 2014 | $116.37M | +68.5% |
| FY2013 | Dec 31, 2013 | $69.07M | -46.7% |
| FY2012 | Dec 31, 2012 | $129.51M | +34.8% |
| FY2011 | Dec 31, 2011 | $96.04M | -33.5% |
| FY2010 | Dec 31, 2010 | $144.31M | +4.8% |
| FY2009 | Dec 31, 2009 | $137.77M | +54.7% |
| FY2008 | Dec 31, 2008 | $89.03M | – |
See a number that looks wrong?